![Melina Higgins](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Melina Higgins
Chairman at GENWORTH FINANCIAL, INC.
Net worth: 2 M $ as of 2024-05-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Richard Mark | M | 70 |
Mylan NV
![]() Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | 4 years |
Harry Korman | M | 66 |
Mylan NV
![]() Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | 4 years |
JoEllen Dillon | F | 60 |
Mylan NV
![]() Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | 10 years |
Ramsey Smith | M | 56 | 13 years | |
Thomas McInerney | M | 67 | 11 years | |
Mark Parrish | M | 68 | 4 years | |
Melissa Trombetta | F | - |
Mylan NV
![]() Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | 4 years |
Jill Goodman | F | 57 | 3 years | |
Gregory Karawan | M | 60 | 16 years | |
G. Conrad | M | 76 | 11 years | |
Sheara Fredman | F | 49 | 22 years | |
Karen Dyson | F | 64 | 4 years | |
Jerome Upton | M | 60 | 14 years | |
Howard Mills | M | 59 | 3 years | |
Bill Szablewski | M | - | 4 years | |
Marcie McClintic Coates | F | - | - | |
Andrea White | F | 58 | 9 years | |
Kelly Saltzgaber | F | 60 | - | |
Burt Park | M | - | - | |
Abhijit Barve | M | - |
Mylan NV
![]() Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | - |
Scott Smith | M | 61 | 2 years | |
Leo Groothuis | M | - | 1 years | |
Rajiv Malik | M | 63 | 4 years | |
Janis Jones | F | 75 |
Women's Leadership Board
John F. Kennedy School
| - |
Diane Nordin | F | 65 |
Antares Midco, Inc.
Antares Unitholder Investment LLC
![]() Antares Unitholder Investment LLC Financial ConglomeratesFinance Antares Unitholder Investment LLC provides middle market capital loan services. The company is headquartered in Chicago, IL. | - |
Wyllie Cornwell | M | 76 | 4 years | |
James Kilts | M | 76 | 4 years | |
Bob Restrepo | M | 73 | 8 years | |
Robert Coury | M | 63 | 4 years | |
Lakshmi Niwas Mittal | M | 73 | 16 years | |
Darren Woodell | M | 48 | 14 years | |
Elaine Sarsynski | F | 68 | 2 years | |
Anthony Mauro | M | 51 |
Mylan NV
![]() Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | 4 years |
Gisselle Acevedo | F | 66 |
Women's Leadership Board
| - |
Mohammed Al-Ardhi | M | - |
John F. Kennedy School
| - |
Amy Rein | F | - | 3 years | |
Jamala Arland | F | 42 | 19 years | |
Mark Hodges | M | 44 | 9 years | |
Michael J. McCullough | M | 53 | 2 years | |
Lara Ramsburg | F | - | - | |
Arun Narayan | M | 53 | - | |
Tanya Baker | F | - | 16 years | |
Melissa Hagerman | F | 57 | 10 years | |
Andrew Enrietti | M | - | - | |
Paula Madoff | F | 56 |
Women's Leadership Board
| - |
Peter L. Malkin | M | 90 |
John F. Kennedy School
| - |
Anil Amin | M | - | - | |
Ramkumar V. Rayapureddy | M | - | - | |
Jennifer Mauer | F | - | - | |
Kristin DiBartolomeo | F | - | - | |
Anne Nobles | M | 67 |
Women's Leadership Board
| - |
Mohammad Khalaf Mohammad Al-Tal | M | 84 |
John F. Kennedy School
| - |
Beth Brooke | F | 64 |
Women's Leadership Board
| - |
Lydie Hudson | F | 45 |
Women's Leadership Board
| - |
Paul Campbell | M | 57 | 4 years | |
Beth Jacobs | F | - |
Women's Leadership Board
| - |
Carol Hamilton | F | 71 |
Women's Leadership Board
| - |
Patricia A. Wilmot | F | 74 |
Women's Leadership Board
| - |
Ellen Kathrine Dyvik | F | - |
John F. Kennedy School
| - |
Ellyn Shook | F | 60 |
Women's Leadership Board
| - |
Gideon Argov | M | 67 |
John F. Kennedy School
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
John Thain | M | 69 | 10 years | |
John Thornton | M | 70 | 23 years | |
Pauline van der Meer Mohr | F | 64 |
Mylan NV
![]() Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | - |
Randy Cowen | M | 73 | 26 years | |
Marty Klein | M | 64 | 4 years | |
Ramon Chavez Márquez | M | 60 | 14 years | |
Patrick Brian Kelleher | M | - | 6 years | |
Kanad Singh Virk | M | 57 | 10 years | |
James Sellers Riepe | M | 80 | 15 years | |
Sheila Harilal Patel | F | - | 18 years | |
Daniel Sheehan | M | 58 | 14 years | |
Stephen Friedman | M | 86 | 8 years | |
Amy R. Corbin | F | - | - | |
Terry Travis | M | - | 13 years | |
Dan Jester | M | - | 18 years | |
Robin Vince | M | 52 | 14 years | |
Michael Goettler | M | 56 | 3 years | |
Lisa Gay | F | 61 | 20 years | |
Tamim Al-Kawari | M | 48 | - | |
Linnea Conrad Roberts | F | - | - | |
James A. Parke | M | 78 | 14 years | |
Kelly Tuminelli | F | 55 | 13 years | |
Alan M. Cohen | M | 73 | 13 years | |
Robert Reffkin | M | 44 | 6 years | |
Dane Holmes | M | 53 | 12 years | |
Lois Juliber | F | 75 | 8 years | |
Kevin D. Schneider | M | 62 | 13 years | |
Jon Winkelried | M | 64 | 14 years | |
James J. Schiro | M | 78 | 5 years | |
Stephanie Bell-Rose | F | 66 | 10 years | |
Steve Strongin | M | - | - | |
Sjoerd Steven Vollebregt | M | 69 |
Mylan NV
![]() Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | - |
Claes Dahlbäck | M | 76 | 12 years | |
Wendy Cameron | F | 64 |
Mylan NV
![]() Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | 16 years |
William H. Bolinder | M | 80 | 9 years | |
John Sheehan | M | 64 |
Mylan NV
![]() Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | 6 years |
William George | M | 81 | 17 years | |
Henry M. Paulson | M | 77 | 8 years | |
Brian Curley | M | 54 | 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 97 | 97.00% |
United Kingdom | 10 | 10.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Melina Higgins
- Personal Network